Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder

NCT07029529 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Apremilast 60mg
OTHER: Placebo

Sponsor

Yale University

Collaborators

[object Object]